memantine vipharm 20mg potahovaná tableta
vipharm s.a., ożarów mazowiecki array - 11425 memantin-hydrochlorid - potahovaná tableta - 20mg - memantin
memantin zentiva 10mg potahovaná tableta
zentiva, k.s., praha ČeskÁ republika - 11425 memantin-hydrochlorid - potahovaná tableta - 10mg - memantin
memantin zentiva 20mg potahovaná tableta
zentiva, k.s., praha ČeskÁ republika - 11425 memantin-hydrochlorid - potahovaná tableta - 20mg - memantin
memigmin 10mg potahovaná tableta
egis pharmaceuticals plc, budapešť array - 11425 memantin-hydrochlorid - potahovaná tableta - 10mg - memantin
memixa 10mg potahovaná tableta
ardez pharma, spol. s r.o., kosoř array - 11425 memantin-hydrochlorid - potahovaná tableta - 10mg - memantin
memixa 20mg potahovaná tableta
ardez pharma, spol. s r.o., kosoř array - 11425 memantin-hydrochlorid - potahovaná tableta - 20mg - memantin
morysa 10mg potahovaná tableta
neuraxpharm bohemia s.r.o., praha array - 11425 memantin-hydrochlorid - potahovaná tableta - 10mg - memantin
morysa 20mg potahovaná tableta
neuraxpharm bohemia s.r.o., praha array - 11425 memantin-hydrochlorid - potahovaná tableta - 20mg - memantin
edarbi
takeda pharma a/s - azilsartan medoxomil - hypertenze - agens působící na systém renin-angiotenzin - přípravek edarbi je určen k léčbě esenciální hypertenze u dospělých.
eucreas
novartis europharm limited - vildagliptin, metformin hydrochloridu - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.